T-cell Acute Lymphoblastic Leukemia

• CLINICAL_TRIALS withdrawal · 2026-03-17
  Clinical Trial Update: A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma [Phase 1, Phase 2]

  A Phase 1/2 CAR-T trial for relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2024-11-14
  Clinical Trial Update: Donor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/Lymphoma [Phase 1]

  A Phase 1 trial of donor-derived CD5 CAR T cells (CT125B) for relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoma has been w…

• CLINICAL_TRIALS withdrawal · 2024-05-17
  Clinical Trial Update: Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) [Phase 2]

  This clinical trial update notes withdrawal of a Phase 2 study evaluating adding targeted drugs to standard chemotherapy for adults with new…

• CLINICAL_TRIALS withdrawal · 2016-12-20
  Clinical Trial Update: Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma [Phase 1, Phase 2]

  This terminated Phase 1/Phase 2 trial studied salvage therapy combining chemotherapy and natural killer (NK) cell therapy for relapsed or re…

• CLINICAL_TRIALS withdrawal · 2012-01-23
  Clinical Trial Update: Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens [Phase 2]

  A Phase 2 study of forodesine hydrochloride in relapsed/refractory precursor T-lymphoblastic leukemia/lymphoma was terminated; no efficacy r…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.